UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Association Between Potentially Inappropriate Prescribing and Medication-Related Hospital Admissions in Older Patients: A Nested Case Control Study

Drug safety, 2016-01, Vol.39 (1), p.79-87

2016

Volltextzugriff (PDF)

Cumulative pemetrexed dose increases the risk of nephrotoxicity

Lung cancer (Amsterdam, Netherlands), 2020-08, Vol.146, p.30-35

2020

Volltextzugriff (PDF)

Influence of antidepressants on glycaemic control in patients with diabetes mellitus

Pharmacoepidemiology and drug safety, 2008-06, Vol.17 (6), p.577-586

2008

Volltextzugriff (PDF)

Limited adherence to safety instructions in drug leaflets

British journal of clinical pharmacology, 2002-12, Vol.54 (6), p.678-679

2002

Volltextzugriff (PDF)

A comparison of the renal function biomarkers serum creatinine, pro-enkephalin and cystatin C to predict clearance of pemetrexed

Cancer chemotherapy and pharmacology, 2024-10

2024

Volltextzugriff (PDF)

The Association between Antidepressant Use and Disturbances in Glucose Homeostasis: Evidence from Spontaneous Reports

Drug safety, 2007, Vol.30 (10), p.919-990

2007

Volltextzugriff (PDF)

Serious intoxication after inhaling methanol

Nederlands tijdschrift voor geneeskunde, 2006-06, Vol.150 (23), p.1298

2006

Volltextzugriff (PDF)

PS-011 Evaluation of clinical rules in a clinical decision support system for hospitalised and nursing home patients

European journal of hospital pharmacy. Science and practice, 2014-03, Vol.21 (Suppl 1), p.A147-A148

2014

Volltextzugriff (PDF)

Impaired glucose homeostasis after imipramine intake in a diabetic patient

Journal of clinical psychopharmacology, 2005-12, Vol.25 (6), p.621-623

2005

Volltextzugriff (PDF)

Detection of inappropriate medication use in the elderly; will the STOPP and START criteria become the new Dutch standards?

Nederlands tijdschrift voor geneeskunde, 2012, Vol.156 (40), p.A5076

2012

Volltextzugriff (PDF)

Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment-TUMMY Study

Pharmaceutics, 2023-03, Vol.15 (3), p.972

2023

Volltextzugriff (PDF)

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2015-10, Vol.149 (4), p.907-917.e7

2015

Volltextzugriff (PDF)

Switching from infliximab innovator to biosimilar in patients with inflammatory bowel disease: a 12‐month multicentre observational prospective cohort study

Alimentary pharmacology & therapeutics, 2018-02, Vol.47 (3), p.356-363

2018

Volltextzugriff (PDF)

Adoption of antithrombotic stewardship and utilization of clinical decision support systems-A questionnaire-based survey in Dutch hospitals

PloS one, 2024-06, Vol.19 (6), p.e0306033

2024

Volltextzugriff (PDF)

Risk factors for thiopurine‐induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype

Alimentary pharmacology & therapeutics, 2017-11, Vol.46 (10), p.953-963

2017

Volltextzugriff (PDF)

Renal function-based versus standard dosing of pemetrexed: a randomized controlled trial

Cancer chemotherapy and pharmacology, 2023-01, Vol.91 (1), p.33-42

2023

Volltextzugriff (PDF)

Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency

Metabolites, 2023-10, Vol.13 (10), p.1054

2023

Volltextzugriff (PDF)

A value proposition for trough level-based anti-TNFα drug dosing

Clinica chimica acta, 2019-02, Vol.489, p.89-95

2019

Volltextzugriff (PDF)

Patients’ beliefs about medicine are associated with early thiopurine discontinuation in patients with inflammatory bowel diseases

European journal of gastroenterology & hepatology, 2018-02, Vol.30 (2), p.167-173

2018

Volltextzugriff (PDF)

More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing

Inflammatory bowel diseases, 2017-10, Vol.23 (10), p.1873-1881

2017

Volltextzugriff (PDF)

Therapeutic drug monitoring (TDM) as a tool in the switch from infliximab innovator to biosimilar in rheumatic patients: results of a 12-month observational prospective cohort study

Clinical rheumatology, 2017-09, Vol.36 (9), p.2129-2134

2017

Volltextzugriff (PDF)

The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naïve Inflammatory Bowel Disease Patients

Inflammatory bowel diseases, 2024-09, Vol.30 (9), p.1492-1499

2024

Volltextzugriff (PDF)

Early Assessment of Thiopurine Metabolites Identifies Patients at Risk of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2017-02, Vol.11 (2), p.175-184

2017

Volltextzugriff (PDF)

Short-term variation in plasma mitotane levels confirms the importance of trough level monitoring

European journal of endocrinology, 2014-12, Vol.171 (6), p.677-683

2014

Volltextzugriff (PDF)

6‐methylmercaptopurine‐induced leukocytopenia during thiopurine therapy in inflammatory bowel disease patients

Journal of gastroenterology and hepatology, 2017-06, Vol.32 (6), p.1183-1190

2017

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(61)

Sprache

Englisch
(59)
Niederländisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(44)
Humans
(41)
Female
(26)
Male
(26)
Adult
(23)
Middle Aged
(22)
Gastroenterology & Hepatology
(18)
Pharmacology & Pharmacy
(18)
Inflammatory Bowel Diseases - Drug Therapy
(16)
Aged
(15)
Inflammatory Bowel Disease
(13)
Azathioprine
(9)
Azathioprine - Adverse Effects
(9)
Azathioprine - Therapeutic Use
(9)
6-Mercaptopurine
(8)
Mercaptopurine - Adverse Effects
(8)
Case-Control Studies
(7)
Immunosuppressive Agents - Therapeutic Use
(7)
Netherlands
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Association Between Potentially Inappropriate Prescribing and Medication-Related Hospital Admissions in Older Patients: A Nested Case Control Study

Cumulative pemetrexed dose increases the risk of nephrotoxicity

Influence of antidepressants on glycaemic control in patients with diabetes mellitus

Limited adherence to safety instructions in drug leaflets

A comparison of the renal function biomarkers serum creatinine, pro-enkephalin and cystatin C to predict clearance of pemetrexed

The Association between Antidepressant Use and Disturbances in Glucose Homeostasis: Evidence from Spontaneous Reports

Serious intoxication after inhaling methanol

PS-011 Evaluation of clinical rules in a clinical decision support system for hospitalised and nursing home patients

Impaired glucose homeostasis after imipramine intake in a diabetic patient

Detection of inappropriate medication use in the elderly; will the STOPP and START criteria become the new Dutch standards?

Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment-TUMMY Study

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease

Switching from infliximab innovator to biosimilar in patients with inflammatory bowel disease: a 12‐month multicentre observational prospective cohort study

Adoption of antithrombotic stewardship and utilization of clinical decision support systems-A questionnaire-based survey in Dutch hospitals

Risk factors for thiopurine‐induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype

Renal function-based versus standard dosing of pemetrexed: a randomized controlled trial

Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency

A value proposition for trough level-based anti-TNFα drug dosing

Patients’ beliefs about medicine are associated with early thiopurine discontinuation in patients with inflammatory bowel diseases

More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing

Therapeutic drug monitoring (TDM) as a tool in the switch from infliximab innovator to biosimilar in rheumatic patients: results of a 12-month observational prospective cohort study

The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naïve Inflammatory Bowel Disease Patients

Early Assessment of Thiopurine Metabolites Identifies Patients at Risk of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease

Short-term variation in plasma mitotane levels confirms the importance of trough level monitoring

6‐methylmercaptopurine‐induced leukocytopenia during thiopurine therapy in inflammatory bowel disease patients

Suchergebnisse filtern